Do Cardiac Biomarkers NT-proBNP and hsTnT Predict Microvascular Events in Patients With Type 2 Diabetes? Results From the ADVANCE Trial
Paul Welsh, Mark Woodward, Graham S Hillis, Qiang Li, Michel Marre, Bryan Williams, Neil Poulter, Louise Ryan, Stephen Harrap, Ansuhka Patel, John Chalmers, Naveed Sattar
Diabetes Care | AMER DIABETES ASSOC | Published : 2014
Awarded by National Health and Medical Research Council (NHMRC) of Australia
Awarded by NHMRC of Australia
Awarded by British Heart Foundation
The ADVANCE trial (clinical trial reg. no. NCT00145925, clinicaltrials.gov) was partially funded by the National Health and Medical Research Council (NHMRC) of Australia (project grant ID 211086 and program grants 358395 and 571281). The biomarker work in the current study was funded by the NHMRC of Australia (project grant 632507) and the Diabetes Australia Research Trust. P. W. is supported by British Heart Foundation fellowship FS/12/62/29889. B. W. is a National Institute for Health Research (NIHR) Senior Investigator and is supported by the NIHR University College London Biomedical Research Centre.